C. J. Rodenburg

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine · 2009 · 1.3K citations · Full text

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Miriam Koopman, Ninja Antonini, Joep Douma et al. · The Lancet · 2007 · 626 citations

Gastrointestinal Oncology, Medicine, Phase Iii +8

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

J. Tol, Miriam Koopman, C. J. Rodenburg et al. · Annals of Oncology · 2008 · 208 citations

Cairo2 Study, Interim Analysis, Oncology +7

Tumor ploidy as a major prognostic factor in advanced ovarian cancer

C. J. Rodenburg, Cees J. Cornelisse, Peter Heintz et al. · Cancer · 1987 · 172 citations · Full text

Residual Tumor, Tumor Bulk, Tumoral Pathology +13

Antiprogestins, a new form of endocrine therapy for human breast cancer.

J.G.M. Klijn, FH de Jong, G.H. Bakker et al. · PubMed · 1989 · 142 citations

Breast Oncology, Gynecology, Human Breast Cancer +18